Ergoteles’s Translate Bio, Inc. Common Stock TBIO Stock Holding History

Ergoteles’s Portfolio TBIO Stock Details TBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-24,000	Closed	-$661K	–	1858
2021 Q2	$661K	Buy	+24,000	New	+$472K	0.02%	671

Ergoteles's TBIO Position: Q3 2021 in Review

Ergoteles sold out of Translate Bio, Inc. Common Stock (TBIO) in Q3 2021, closing a stake of 24,000 shares — an estimated $661K sold.

Ergoteles first reported a position in TBIO in Q2 2021 and held it in 1 quarter. The position peaked at $661K in Q2 2021. 0 funds tracked by Wall St. Rank hold TBIO as of Q3 2021.

Ergoteles reported no remaining Translate Bio, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
Ergoteles sold 24,000 Translate Bio, Inc. Common Stock shares in Q3 2021, an estimated $661K.
Ergoteles first reported a position in Translate Bio, Inc. Common Stock in Q2 2021 and held it in 1 quarter.
Ergoteles's Translate Bio, Inc. Common Stock position peaked at $661K in Q2 2021.
0 funds tracked by Wall St. Rank held Translate Bio, Inc. Common Stock as of Q3 2021.

Based on Ergoteles's 13F filing for Q3 2021, filed 15 Nov 2021.